Search Results
VTE Risk, Recurrence in Cancer Patients Treated With Anticoagulants
22. Anticoagulation in high bleeding risk cancer patients - Dr Nolukholo Ncete
To reduce VTE recurrence, keep patients with active cancers on anticoagulation therapy
Recent Clinical Trials Related to VTE
Risk of Recurrent Venous Thromboembolism
The Clot Thickens: anticoagulation in oncology patients
Risk of VTE Recurrence with Subsegmental PE not anticoagulated
Apixaban reduced thromboembolism risk in cancer patients
Medical Therapy for Venous Thromboembolism | Gregory Piazza, MD, MS
Anticoagulation Treatment - The key to managing VTE explained
Oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism
CASSINI: can we prevent thrombosis in cancer patients who are at risk?
